Neurotech Competitors and Similar CompaniesClear all

Aptinyx's competitors and similar companies include Adicet Bio and Rubius Therapeutics.
Aptinyx
Aptinyx
Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders.
Adicet Bio
Adicet Bio
Adicet Bio is a biotechnology company that develops therapies for cancer diseases.
Rubius Therapeutics
Rubius Therapeutics
Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
Founding Date
Founding Date
2015
Founding Date
2016
Founding Date
2013
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Evanston, US HQ
Evanston, US
Locations
Redwood City, US HQ
Boston, US
Locations
Cambridge, US HQ
Smithfield, US
Employees
Employees
635% increase
Employees
1438% increase
Employees
17423% increase
Valuation ($)
Valuation ($)
4.1 m
Valuation ($)
116.2 m
Valuation ($)
7.5 m

Financial

Net income
Net income
($64.8m) (FY, 2022)
Net income
($116.8m) (FY, 2025)
Net income
($179.7m) (FY, 2022)

Funding

Total funding raised
Total funding raised
$ 135m
Total funding raised
$ 145.6m
Total funding raised
$ 245m
For sources of this data, please see the company profile

View Company Profiles

Adicet Bio
HQ
Redwood City, US
Employees
143↑ 8% increase

Adicet Bio is a biotechnology company that develops therapies for cancer diseases.

View company
Rubius Therapeutics
HQ
Cambridge, US
Employees
174↑ 23% increase

Rubius is developing a new class of drugs, Red-Cell Therapeutics™.

View company